Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
Indexy online
AD Index online
select
AD Index online
 

STRATA Skin Scn Rg
Poslední obchod Změna (%) Změna Objem obchodů ()
- - -
Poslední obchod Změna (%) Změna Objem obchodů ()
- - -
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 14.02.2026
Popis společnosti
Obecné informace
Název společnostiSTRATA Skin Sciences Inc
TickerSSKN
Kmenové akcie:Ordinary Shares
RICSSKN.O
ISIN-
Prioritní akciePreference Shares
Prioritní akcieConv. Pref. Shrs
Poslední známé roční výsledky31.12.2024
Poslední známé čtvrtletní výsledky30.06.2025
Počet zaměstnanců k 31.12.2024 106
Akcie v oběhu k 03.09.2025 5 268 708
MěnaUSD
Kontaktní informace
Ulice5 Walnut Grove Drive, Suite 140
MěstoHORSHAM
PSČ19044
ZeměUnited States
Kontatní osoba 
Funkce kontaktní osoby 
Telefon12 156 193 200
Fax12156193209

Business Summary: STRATA Skin Sciences, Inc. is a medical technology company in dermatology. The Company is engaged in developing, commercializing and marketing products for the treatment of dermatologic conditions. The Company operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Company’s products include the XTRAC and Pharos excimer lasers and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its products also include the TheraClear Acne Therapy System utilized in the treatment of mild to moderate inflammatory, comedonal and pustular acne. The XTRAC and Pharos excimer laser technology emits highly concentrated ultraviolet (UV) light targeted primarily towards autoimmune dermatological skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. VTRAC is a UV light lamp system that works in much the same way as the XTRAC.
Financial Summary: BRIEF: For the six months ended 30 June 2025, STRATA Skin Sciences Inc revenues decreased 5% to $14.5M. Net loss increased 42% to $4.9M. Revenues reflect Foreign segment decrease of 69% to $935K. Higher net loss reflects Unallocated segment loss increase from $2.2M to $5.5M, Dermatology Procedures Equipment segment loss totaling $80K vs. income of $959K. Basic Earnings per Share excluding Extraordinary Items decreased from -$0.99 to -$1.18.
Odvětvová klasifikace
TRBC2009Advanced Medical Equipment
TRBC2012Advanced Medical Equipment & Technology (NEC)
RBSS2004Advanced Medical Equipment
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSElectromedical and Electrotherapeutic Apparatus Manufacturing
NAICS2007Electromedical Apparatus Mfg
NAICS2007Offices of Physicians (exc Mental Health)
NAICS1997Electromedical and Electrotherapeutic Apparatus Manufacturing
NAICS1997Offices of Physicians (except Mental Health Specialists)
SICSurgical And Medical Instruments
SICElectromedical Equipment



  • Poslední aktualizace: 14.02.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
President, Chief Executive Officer, Vice Chairman of the BoardDolev Rafaeli6130.10.202310.04.2018
Chief Operating OfficerShmuel Gov6614.11.202301.01.2021
Chief Accounting OfficerJohn Gillings4905.08.2024